Hemolytic Jaundice In Newborns

Authors

  • Tolipova Noila Kudratovna , Latipova Shakhnoza Akbarbekovna , Azimova Sevara Bakhodirovna

DOI:

https://doi.org/10.47750/pnr.2022.13.S07.193

Abstract

Neonatal jaundice that occurs in ABO or Rhesus issoimunisation has been recognized as one of the major risk factors for development of severe hyperbilirubinemia and bilirubin neurotoxicity.

Downloads

Published

2022-12-14 — Updated on 2022-12-14

Versions

Issue

Vol. 13 SPECIAL ISSUE 07 (2022)

Section

Articles

How to Cite

Hemolytic Jaundice In Newborns. (2022). Journal of Pharmaceutical Negative Results, 1317-1321. https://doi.org/10.47750/pnr.2022.13.S07.193